Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
BG Medicine, Inc. (BGMD) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/17/2015 8-K Quarterly results
Docs: "BG Medicine Reports Third Quarter 2015 Financial Results Waltham, Mass., November 17, 2015 - BG Medicine, Inc. , the developer of the BGM Galectin-3 ® Test, today reported financial results for the three and nine months ended September 30, 2015. “Our operating results in the third quarter of 2015 reflect our ongoing efforts to extend our cash runway through the prudent and disciplined management of our resources, “ said Paul R. Sohmer, M.D., President and CEO of BG Medicine . “The commercialization of automated testing for galectin-3 in the U.S. was initiated in the third quarter. As a result, we continue to expect that product fees generated through the initial sales of automated tests for galectin-3 in the U.S. and payable to the Company by Abbott will be reported next quarter.” Third Qu..."
08/14/2015 8-K Quarterly results
Docs: "BG Medicine Provides Business Update and Reports Second Quarter 2015 Financial Results Focus Shifts to Support of Market Introduction of Automated Galectin-3 Test in U.S. Operating Cash Burn for Second Quarter of 2015 Reduced by 68% from Second Quarter of 2014"
05/14/2015 8-K Quarterly results
Docs: "BG Medicine Reports First Quarter 2015 Financial Results Net Loss Reduced by 38% and Operating Cash Burn Cut by 42% from First Quarter 2014 Outlook Improved for 2015"
03/31/2015 8-K Quarterly results
Docs: "BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results Net Loss Reduced by 49% and Operating Cash Burn Cut by 47% From 2013 First Automated Galectin-3 Testing Expected to Launch in U.S. in Mid-2015"
11/13/2014 8-K Quarterly results
Docs: "BG Medicine Reports Third Quarter 2014 Financial Results Net Loss Reduced by 35% and Operating Cash Burn Cut by 48% From Third Quarter 2013 Company Retains Investment Bank to Explore Strategic Alternatives"
08/14/2014 8-K Quarterly results
Docs: "BG Medicine Reports Second Quarter 2014 Financial Results Net Loss Reduced by 55% and Operating Cash Burn Cut by 43% From Second Quarter 2013"
05/14/2014 8-K Quarterly results
Docs: "BG MEDICINE REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS Net Loss Reduced by 60% and Operating Cash Burn Cut by 44% from First Quarter 2013 Continued Progress Made Toward Delivering on Critical Catalysts for Growth"
03/20/2014 8-K Quarterly results
Docs: "BG Medicine Reports 2013 Fourth Quarter and Year End Financial Results"
11/06/2013 8-K Form 8-K - Current report
08/08/2013 8-K Form 8-K - Current report
05/09/2013 8-K Form 8-K - Current report
03/13/2013 8-K Form 8-K - Current report
11/13/2012 8-K Form 8-K - Current report
08/09/2012 8-K Form 8-K - Current report
05/15/2012 8-K Form 8-K - Current report
03/08/2012 8-K Form 8-K - Current report
11/03/2011 8-K Form 8-K - Current report
08/11/2011 8-K Form 8-K - Current report
05/12/2011 8-K Form 8-K - Current report
03/16/2011 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy